Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Abstract Text:

Polysorbates 20 and 80 (Tween 20 and Tween 80) are used in the formulation of biotherapeutic products for both preventing surface adsorption and as stabilizers against protein aggregation. The polysorbates are amphipathic, nonionic surfactants composed of fatty acid esters of polyoxyethylene sorbitan being polyoxyethylene sorbitan monolaurate for polysorbate 20 and polyoxyethylene sorbitan monooleate for polysorbate 80. The polysorbates used in the formulation of biopharmaceuticals are mixtures of different fatty acid esters with the monolaurate fraction of polysorbate 20 making up only 40-60% of the mixture and the monooleate fraction of polysorbate 80 making up >58% of the mixture. The polysorbates undergo autooxidation, cleavage at the ethylene oxide subunits and hydrolysis of the fatty acid ester bond. Autooxidation results in hydroperoxide formation, side-chain cleavage and eventually formation of short chain acids such as formic acid all of which could influence the stability of a biopharmaceutical product. Oxidation of the fatty acid moiety while well described in the literature has not been specifically investigated for polysorbate. This review focuses on the chemical structure of the polysorbates, factors influencing micelle formation and factors and excipients influencing stability and degradation of the polyoxyethylene and fatty acid ester linkages.

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of pharmaceutical sciences

VOLUME: 97

Page Numbers: 2924-35

Journal Abbreviation:

ISSN: 1520-6017

DAY: 28

MONTH: Aug

YEAR: 2008

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985195

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.

AFFILIATION: Department of Pharmaceutics, Amgen Inc., One Amgen Center Dr., Thousand Oaks, California 91320, USA. bkerwin@amgen.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pharm Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways Related Publications

• A faith-based intervention for cocaine-dependent Black women.
• An analytical examination of muscle force estimations using optimization techniques.
• Biological determinants of difficult to treat patients with schizophrenia.
• Cardiac alert: decreasing door-to-balloon time for ST elevation myocardial infarction.
• Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography.
• Coupling reactions of bromoalkynes with imidazoles mediated by copper salts: synthesis of novel N-alkynylimidazoles.
• Enediynes from aza-enediynes: C,N-dialkynyl imines undergo both aza-Bergman rearrangement and conversion to enediynes and fumaronitriles.
• Identification of the adduct between a 4-Aza-3-ene-1,6-diyne and DNA using electrospray ionization mass spectrometry.
• Musculoskeletal demands of progressions for the longswing on high bar.
• Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
• Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia.
• Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography.
• Serotonergic polymorphisms and psychotic disorders in populations from North Spain.
• Simian Virus 40 Large T-Antigen G-Quadruplex DNA Helicase Inhibition by G-Quadruplex DNA-Interactive Agents.
• Some aspects of coronary atherosclerosis and its sequelae.
• Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.
• Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1.